Rocket


News + Filings
Transactions





Williams Lewis T

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
01/16/2023Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)30k$12.17$365.1k 01/16/2023
05/26/2022Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)20k$8.31$166.2k 05/26/2022
02/08/2022Arcellx, Inc. ConversionCommon Stock2.1M$0.00$0See footnote02/08/2022
02/08/2022Arcellx, Inc. ConversionSeries B-1 Preferred Stock1.2M$0.00$0See footnote02/08/2022
02/08/2022Arcellx, Inc. ConversionSeries B-2 Preferred Stock931.2k$0.00$0See footnote02/08/2022
05/27/2021Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)18k$35.23$634.1k 05/27/2021
05/11/2021Neoleukin Therapeutics, Inc.AQXPGrantStock Option (Right to Buy)25k$11.40$285k 05/11/2021
05/28/2020Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)15k$16.54$248.1k 05/28/2020
05/05/2020Neoleukin Therapeutics, Inc.AQXPGrantStock Option (Right to Buy)25k$12.84$321k 05/05/2020
10/10/2019Neoleukin Therapeutics, Inc.AQXPGrantStock Option (right to buy)22k$2.82$62k 10/10/2019
09/01/2019FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock7k$5.43$38.1k 09/01/2019
06/10/2019FIVE PRIME THERAPEUTICS, INC.FPRXGrantStock Option (right to buy)15k$6.09$91.4k 06/10/2019
06/07/2019Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)12k$11.80$141.6k 06/07/2019
02/26/2019FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock926$11.95$11.1k 02/26/2019
02/25/2019FIVE PRIME THERAPEUTICS, INC.FPRXGrantCommon Stock1000$0.00$0 02/25/2019
02/25/2019FIVE PRIME THERAPEUTICS, INC.FPRXGrantEmployee Stock Option (right to buy)6.4k$11.97$76.6k 02/25/2019
02/05/2019FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock3.1k$11.43$35.9k 02/05/2019
11/05/2018FIVE PRIME THERAPEUTICS, INC.FPRXExerciseEmployee Stock Option (right to buy)91.2k$4.56$415.9k 11/05/2018
09/01/2018FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock7k$14.00$98.3k 09/01/2018
05/29/2018Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)12k$6.98$83.8k 05/29/2018
02/26/2018FIVE PRIME THERAPEUTICS, INC.FPRXGrantCommon Stock5k$0.00$0 02/26/2018
02/26/2018FIVE PRIME THERAPEUTICS, INC.FPRXGrantEmployee Stock Option (right to buy)30k$18.69$560.7k 02/26/2018
02/05/2018FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock3.1k$18.42$57.8k 02/05/2018
09/01/2017FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock7.8k$34.34$268.8k 09/01/2017
06/15/2017Protagonist Therapeutics, IncPTGXGrantStock Option (right to buy)24k$10.84$260.2k 06/15/2017
03/01/2017FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock34.5k$44.77$1.5M 03/01/2017
02/07/2017FIVE PRIME THERAPEUTICS, INC.FPRXGrantCommon Stock16.9k$0.00$0 02/07/2017
02/07/2017FIVE PRIME THERAPEUTICS, INC.FPRXGrantEmployee Stock Option (right to buy)101.2k$45.38$4.6M 02/07/2017
01/03/2017FIVE PRIME THERAPEUTICS, INC.FPRXPayment of ExerciseCommon Stock5.1k$48.60$246.2k 01/03/2017
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXSaleCommon Stock29.7k$50.49$1.5M 12/23/2016
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXSaleCommon Stock300$51.02$15.3k 12/23/2016
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXExerciseEmployee Stock Option (right to buy)155$4.56$706.8 12/23/2016
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXExerciseEmployee Stock Option (right to buy)19$6.89$130.9 12/23/2016
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXExerciseEmployee Stock Option (right to buy)10$8.49$84.9 12/23/2016
12/23/2016FIVE PRIME THERAPEUTICS, INC.FPRXExerciseEmployee Stock Option (right to buy)29.8k$5.54$165.2k 12/23/2016
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy